NAD+ Injections for Longevity: What the Evidence Says

NAD+ (nicotinamide adenine dinucleotide) has moved from an obscure biochemistry concept to one of the most talked-about longevity interventions in the past decade. The science behind it is legitimate — it plays a central role in cellular energy metabolism and DNA repair, and NAD+ levels decline meaningfully with age. What's more contested is the question of which delivery method, which precursor, and at what dose actually produces meaningful human outcomes.

Injectable NAD+ sits at the more aggressive end of the supplementation spectrum. This post covers the biology, the delivery options, and what tracking a daily injectable protocol actually requires.

Why NAD+ Matters

NAD+ is a coenzyme found in every living cell. It's required for the function of over 500 enzymes and is particularly central to:

Cellular energy production. NAD+ is a critical electron carrier in the mitochondrial electron transport chain — the process by which cells convert nutrients to ATP (usable energy). Without adequate NAD+, this process is impaired.

DNA repair. PARP enzymes, which repair DNA strand breaks, require NAD+ as a substrate. DNA damage accumulates with age; NAD+ depletion limits the cell's ability to fix it.

Sirtuin activation. Sirtuins are a family of proteins associated with longevity, metabolic regulation, and stress resistance. They require NAD+ to function. The sirtuin-NAD+ connection is central to why NAD+ research intersects with aging biology.

Circadian clock function. NAD+ levels fluctuate with circadian rhythm, and disruption of this oscillation is associated with metabolic dysfunction and accelerated aging.

The decline in NAD+ with age — estimates suggest a roughly 50% decline from young adulthood to older age — is one of the well-established features of cellular aging.

Injectable vs. Oral Precursors

Most people exploring NAD+ supplementation start with oral precursors — NMN (nicotinamide mononucleotide) or NR (nicotinamide riboside) — that the body converts into NAD+. The oral options are convenient, reasonably priced, and have growing research support.

Injectable NAD+ delivers the molecule directly without the conversion step. The claimed advantages:

• Immediate bioavailability — no conversion required
• Higher plasma NAD+ levels than oral precursors at equivalent doses (some evidence supports this)
• Faster subjective effect — many people report feeling IV or IM NAD+ effects more acutely than oral precursors
• Certainty of delivery — oral bioavailability of NAD+ is complicated by gut metabolism; injection bypasses this entirely

The tradeoffs: injectable NAD+ requires refrigeration, sterile technique, and daily administration. Intravenous infusion (the most acute delivery method, used in clinics) requires professional administration and can cause significant flushing, nausea, and discomfort if infused too rapidly.

Subcutaneous or intramuscular injection — the home-use approach — is generally better tolerated than IV and still bypasses GI metabolism.

Dosing

Injectable NAD+ dosing varies considerably across protocols:

Subcutaneous/Intramuscular:

• 25–100 mg per injection
• Daily injections
• Some protocols use 50 mg/day as a starting maintenance dose

IV infusion (clinical setting):

• 500–1000 mg over several hours
• Weekly to monthly sessions
• Typically used as loading or reset protocol; not a daily practice

For daily subcutaneous or IM injection at home, 50–100 mg daily is the common range. Starting at the lower end allows you to assess tolerance and adjust.

Reconstitution: NAD+ for injection comes lyophilized and is reconstituted with sterile or bacteriostatic water. Proper storage (refrigerated after reconstitution) and sterile technique are essential.

What People Notice

The subjective effects reported by people using injectable NAD+ are reasonably consistent:

• Energy and mental clarity — often described as a "cleaner" energy than stimulants; more background vitality than foreground buzz
• Improved mood and motivation — the sirtuin and mitochondrial connections both have downstream effects on neurotransmitter metabolism
• Better physical recovery — particularly after intense exercise
• Sleep quality — some report improved sleep; circadian effects of NAD+ are plausible mechanistically
• Acute flushing/discomfort — particularly with rapid IV administration; less common with slow subcutaneous injection but still reported

Effects aren't instant or dramatic for most people. The more reliable reports are about sustained wellbeing over weeks of consistent use rather than acute effects from a single dose.

The Evidence Landscape

The human clinical evidence for NAD+ precursors and direct supplementation has grown substantially. Key findings:

• Oral NR and NMN do raise blood NAD+ levels in humans — this is established
• Whether raised NAD+ levels translate to meaningful health outcomes in healthy adults is still being studied; most positive results are in animal models or populations with specific metabolic conditions
• IV NAD+ has shown interesting results in addiction medicine contexts
• Older and metabolically compromised individuals may have more to gain from NAD+ restoration than young, healthy people

The honest position: the mechanistic rationale is strong, the animal data is consistently positive, and the human data is promising but still catching up. NAD+ supplementation is unlikely to be ineffective, but the magnitude of effect in healthy individuals and the optimal delivery method remain open questions.

Stacking with Other Longevity Protocols

NAD+ is commonly paired with:

• Epithalon — telomere and cellular aging focus
• Resveratrol/Pterostilbene — sirtuin activators; the NAD+/sirtuin connection makes these complementary
• NMN oral — some people use injectable NAD+ for loading phases and oral NMN for maintenance
• Methylene blue — mitochondrial function; often stacked in biohacking contexts

Tracking a Daily Injectable Protocol

Daily subcutaneous injection requires daily logging. For a compound where the primary benefits are cumulative and measured over months, the tracking serves three purposes:

Compliance. Missing doses in a daily protocol erodes the intended steady-state. A log makes missed doses visible rather than invisible.

Protocol management. Dose adjustments, reconstitution batches, and injection site rotation all need documentation to be managed reliably.

Outcome measurement. NAD+'s proposed benefits are diffuse — energy, recovery, mood, cognitive function. Without consistent daily rating of these domains, you can't assess whether the protocol is working. The measurements that matter:

• Daily energy and vitality rating (0–10)
• Sleep quality (0–10, logged on waking)
• Cognitive clarity rating (subjective, consistent time of day)
• Physical recovery after training sessions
• Body weight and body composition (monthly or quarterly)
• Bloodwork: NAD+ metabolite levels, standard metabolic panel, inflammatory markers (baseline and quarterly)

The pairing problem. Most people running injectable NAD+ are also running other longevity interventions. Isolating NAD+'s contribution from a multi-compound protocol is genuinely difficult. A detailed protocol log — noting every compound, every dose change, every new addition — is the only way to retrospectively interpret what's doing what. Milos handles the daily logging side — dose timestamps, energy and mood ratings, injection site rotation, and protocol history — so the data is there when you review it against your bloodwork.

Safety

NAD+ is an endogenous molecule the body makes and uses constantly. The safety profile of supplemental NAD+ is favorable.

Common side effects:

• Flushing — niacin-like flush, particularly with IV administration or higher doses; generally transient
• Nausea — at high or rapid doses
• Injection site reactions — standard for subcutaneous injection

No significant long-term adverse effects have been documented in the clinical literature.

Bottom Line

NAD+ injectable protocols sit at the serious end of longevity supplementation — more logistically demanding than oral options, with plausible evidence for superior bioavailability, and a mechanistic basis that's among the more solid in the anti-aging space.

Daily administration requires daily tracking. The benefits are cumulative and diffuse enough that without consistent measurement, you're guessing at the outcome. A structured log paired with regular bloodwork is what separates active protocol management from passive hope.